Výsledky vyhledávání - Liu, Huaxiang
- Zobrazuji výsledky 1 - 17 z 17
-
1
-
2
-
3
Effects of Exogenous Galanin on Neuropathic Pain State and Change of Galanin and Its Receptors in DRG and SDH after Sciatic Nerve-Pinch Injury in Rat Autor Xu, Xiaofeng, Yang, Xiangdong, Zhang, Ping, Chen, Xiuying, Liu, Huaxiang, Li, Zhenzhong
Vydáno 2012Text -
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis Autor Yuan, Min, Wang, Shujun, Yu, Lijie, Qu, Bo, Xu, Liming, Liu, Lining, Sun, Huanxia, Li, Chunxian, Shi, Yanjun, Liu, Huaxiang
Vydáno 2017Text -
12
Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials Autor Sholter, Dalton, Wu, Jianmin, Jia, Bochao, Zhang, Hong, Griffing, Kirstin, Birt, Julie, Reis, Paulo Jorge Simoes, Liu, Huaxiang, Bingham, Clifton O.
Vydáno 2022Text -
13
Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study Autor Zeng, Xiaofeng, Liu, Ju, Liu, Xiumei, Wu, Lijun, Liu, Yi, Liao, Xiangping, Liu, Huaxiang, Hu, Jiankang, Lu, Xin, Chen, Linjie, Xu, Jian, Jiang, Zhenyu, Lu, Fu-ai, Wu, Huaxiang, Li, Ying, Wang, Qingyu, Zhu, Jun
Vydáno 2022Text -
14
Comparison of the Efficacy and Safety of Adalimumab (Humira) and the Adalimumab Biosimilar Candidate (HS016) in Chinese Patients with Active Ankylosing Spondylitis: A Multicenter,... Autor Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
Vydáno 2020Text -
15
Changes in Efficacy Indicators for Adalimumab Biosimilar Candidate (HS016) for the Treatment of Active Ankylosing Spondylitis at Various Time Points Autor Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
Vydáno 2020Text -
16
Evaluation of adalimumab biosimilar candidate (HS016) in Chinese patients with active ankylosing spondylitis based on a health survey: sub-analysis of a phase 3 study Autor Su, Jinmei, Li, Mengtao, He, Lan, Zhao, Dongbao, Wan, Weiguo, Liu, Yi, Xu, Jianhua, Xu, Jian, Liu, Huaxiang, Jiang, Lindi, Wu, Huaxiang, Zuo, Xiaoxia, Huang, Cibo, Liu, Xiumei, Li, Fen, Zhang, Zhiyi, Liu, Xiangyuan, Dong, Lingli, Li, Tianwang, Chen, Haiying, Li, Jingyang, He, Dongyi, Lu, Xin, Huang, Anbin, Tao, Yi, Wang, Yanyan, Zhang, Zhuoli, Wei, Wei, Li, Xiaofeng, Zeng, Xiaofeng
Vydáno 2021Text -
17
Prevalence and risk factors of active tuberculosis in patients with rheumatic diseases: a multi-center, cross-sectional study in China Autor Liu, Xiaoqing, Zhang, Lifan, Zhang, Fengchun, Zeng, Xiaofeng, Zhao, Yan, Wang, Qian, Liu, Shengyun, Zuo, Xiaoxia, Zhang, Zhiyi, Wu, Huaxiang, Chen, Sheng, Li, Hongbin, Zhu, Ping, Wu, Lijun, Qi, Wencheng, Liu, Yi, Zhang, Miaojia, Liu, Huaxiang, Xu, Dong, Zheng, Wenjie, Zhang, Yueqiu, Shi, Xiaochun, Han, Lishuai, Zhou, Yaou, Zhao, Yanping, Wang, Wenwen, Li, Ting, Tie, Ning, Zhang, Kui, Luo, Cainan, Gong, Baoqi, Zhao, Yi, Lv, Chengyin, Song, Lijun, Wu, Qingjun, Fei, Yunyun, Zhang, Lei, Luo, Hui, Sun, Jiaying, Xue, Jing, Gu, Liyang, Wang, Jing, Han, Qing, Yimaity, Kuerbanjiang, Zhou, Jiaxin, Zhao, Lidan, Bian, Sainan, Qi, Wufang, Li, Yanhong, Zhu, Yujing, Han, Huijun, Liao, Susu, Liu, Gaifen
Vydáno 2021Text